For the first three quarters, exportation of China’s bio-med hit USD 1.7 billion and importation reached USD 2.7 billion.

The Heparin Sodium and Peptone derivatives products accounted for nearly half of China’s bio-med exportation. Most of the countries been exported to are advanced countries. And Asia, Europe and U.S. consumed almost 69% of the China’s exportation.

As for the importation, human-used and vet-used vaccine drive the increase trends.